SEDAR Interim Financial Statements

[
  {
    "companyName": "Doseology Sciences Inc.",
    "reportingPeriodEnd": "2025-12-31",
    "reportStatus": "Unaudited",
    "auditorName": null,
    "auditorKeyMatters": [],
    "balanceSheet": {
      "cashAndCashEquivalents": 661936,
      "receivables": 69544,
      "prepaidExpensesAndDeposits": 235785,
      "inventories": 83416,
      "totalCurrentAssets": 1050681,
      "goodwill": 347000,
      "totalAssets": 1397681,
      "accountsPayableAndAccruedLiabilities": 81257,
      "totalCurrentLiabilities": 81257,
      "totalLiabilities": 81257,
      "shareCapital": 7901753,
      "reserves": 492589,
      "deficit": -7077918,
      "totalShareholdersEquity": 1316424,
      "totalLiabilitiesAndShareholdersEquity": 1397681,
      "cashPerShare": 0.0826,
      "workingCapitalPerShare": 0.1209
    },
    "incomeStatement": {
      "productSales": 49216,
      "costOfSales": -32379,
      "grossProfit": 16837,
      "marketingAndProductPlacement": 68582,
      "investorRelations": 30000,
      "productDevelopmentAndOtherCosts": 0,
      "consultingFees": 32508,
      "managementFees": 105500,
      "professionalFees": 76913,
      "regulatoryFilingsAndListingFees": 1181,
      "office": 16892,
      "salariesAndBenefits": 60561,
      "shareBasedCompensation": -30508,
      "depreciationAndAmortization": 0,
      "totalExpenses": -361629,
      "interestAndOtherIncome": 5477,
      "gainOnLeaseTermination": 0,
      "lossOnAssetDisposal": 0,
      "lossAndComprehensiveLossForThePeriod": -339315,
      "lossPerShareBasicAndDiluted": -0.04,
      "weightedAverageNumberOfSharesOutstandingBasicAndDiluted": 8011621
    },
    "cashFlowStatement": {
      "lossForThePeriod": -511228,
      "shareBasedCompensation": 29986,
      "changesInNonCashWorkingCapitalItemsReceivables": -27646,
      "changesInNonCashWorkingCapitalItemsPrepaidExpensesAndDeposits": -231900,
      "changesInNonCashWorkingCapitalItemsInventories": -33032,
      "changesInNonCashWorkingCapitalItemsAccountsPayableAndAccruedLiabilities": -12850,
      "cashUsedInOperatingActivities": -767724,
      "decreaseInCashDuringThePeriod": -767724,
      "cashBeginningOfThePeriod": 1429660,
      "cashEndOfThePeriod": 661936
    },
    "investmentsAndOtherAssets": [],
    "shareStructure": {
      "authorizedShares": "Unlimited number of voting common shares without par value",
      "issuedShares": 8011621,
      "classesOfShares": ["Common shares"],
      "warrants": [
        {
          "number": 3336106,
          "exercisePrice": 0.5,
          "expiryDate": "2027-06-12"
        }
      ],
      "options": [
        {
          "number": 115000,
          "exercisePrice": 1,
          "expiryDate": "2028-03-30"
        },
        {
          "number": 40000,
          "exercisePrice": 0.4,
          "expiryDate": "2029-09-12"
        },
        {
          "number": 155000,
          "exercisePrice": 0.4,
          "expiryDate": "2029-05-01"
        }
      ],
      "rightsConvertibleInstruments": null
    },
    "managementCompensation": {
      "currency": "CAD",
      "periods": {
        "2025-12-31": {
          "managementFees": 143500,
          "professionalFees": 60683,
          "shareBasedCompensation": 0
        },
        "2024-12-31": {
          "managementFees": 3000,
          "professionalFees": 0,
          "shareBasedCompensation": 13564
        }
      },
      "namedIndividuals": [
        {
          "name": "Christopher Cherry",
          "title": "Chief Financial Officer",
          "period": "2025-12-31",
          "components": {
            "salary": 6000,
            "bonus": null,
            "total": 6000
          }
        },
        {
          "name": "Tim Corkum",
          "title": "Chief Operating Officer",
          "period": "2025-12-31",
          "components": {
            "salary": 87500,
            "bonus": null,
            "total": 87500
          }
        }
      ],
      "otherRelatedPartyTransactions": [
        {
          "counterparty": "Law firm where Scott Reeves is a partner",
          "description": "Professional fees",
          "amount": 60683,
          "period": "2025-12-31"
        }
      ]
    },
    "subsequentEvents": []
  }
]